Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ib/II Study of hSTC810 in Combination With Paclitaxel in Relapsed or Refractory Extensive Stage Small Cell Lung Cancer

NCT06016270 is registered in ClinicalTrials.gov with STCube, Inc. as lead sponsor.

NCT NCT06016270
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06016270 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ib/II Study of hSTC810 in Combination With Paclitaxel in Relapsed or Refractory Extensive Stage Small Cell Lung Cancer
Lead sponsor
STCube, Inc.
Phase
Phase 1/2
Overall status
Terminated
Start date
February 13, 2024
Completion date
August 25, 2025
Enrollment
10 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

extensive stage small cell lung cancer